Hisamitsu Pharmaceutical Co., Inc. (FRA:HPX)
Germany
· Delayed Price · Currency is EUR 23.00
+0.20 (0.88%)
At close: Dec 5, 2025
FRA:HPX Ratios and Metrics
Market cap in millions EUR. Fiscal year is March - February.
Millions EUR. Fiscal year is Mar - Feb.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2016 - 2020 |
| Market Capitalization | 1,615 | 1,970 | 1,812 | 2,102 | 2,294 | 4,206 | Upgrade
|
| Market Cap Growth | -17.56% | 8.75% | -13.80% | -8.39% | -45.45% | 27.38% | Upgrade
|
| Enterprise Value | 1,018 | 1,258 | 1,069 | 1,090 | 1,213 | 3,189 | Upgrade
|
| Last Close Price | 23.00 | 26.42 | 22.57 | 24.39 | 25.48 | 48.33 | Upgrade
|
| PE Ratio | 14.10 | 14.16 | 21.01 | 25.86 | 30.75 | 58.67 | Upgrade
|
| PS Ratio | 1.78 | 1.98 | 2.07 | 2.37 | 2.47 | 4.74 | Upgrade
|
| PB Ratio | 1.03 | 1.10 | 1.10 | 1.18 | 1.17 | 2.14 | Upgrade
|
| P/TBV Ratio | 1.07 | 1.14 | 1.14 | 1.19 | 1.18 | 2.16 | Upgrade
|
| P/FCF Ratio | 32.38 | 59.96 | 55.74 | 62.38 | 19.05 | 278.60 | Upgrade
|
| P/OCF Ratio | 16.76 | 16.42 | 16.13 | 23.86 | 15.47 | 102.61 | Upgrade
|
| EV/Sales Ratio | 1.18 | 1.26 | 1.22 | 1.23 | 1.31 | 3.59 | Upgrade
|
| EV/EBITDA Ratio | 7.24 | 7.80 | 9.44 | 9.52 | 11.50 | 27.90 | Upgrade
|
| EV/EBIT Ratio | 9.90 | 10.41 | 13.15 | 13.58 | 16.82 | 38.57 | Upgrade
|
| EV/FCF Ratio | 20.42 | 38.30 | 32.88 | 32.35 | 10.07 | 211.27 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | 0.15 | 0.11 | 0.14 | 0.18 | 0.11 | Upgrade
|
| Debt / FCF Ratio | 0.28 | 0.75 | 0.40 | 0.47 | 0.16 | 0.82 | Upgrade
|
| Asset Turnover | 0.45 | 0.46 | 0.44 | 0.42 | 0.40 | 0.38 | Upgrade
|
| Inventory Turnover | 2.62 | 2.98 | 3.13 | 3.15 | 2.87 | 2.67 | Upgrade
|
| Quick Ratio | 3.21 | 3.73 | 3.66 | 4.15 | 5.61 | 5.83 | Upgrade
|
| Current Ratio | 3.87 | 4.32 | 4.22 | 4.68 | 6.22 | 6.59 | Upgrade
|
| Return on Equity (ROE) | 7.39% | 8.16% | 5.49% | 4.72% | 3.88% | 3.74% | Upgrade
|
| Return on Assets (ROA) | 3.28% | 3.52% | 2.56% | 2.35% | 1.94% | 2.20% | Upgrade
|
| Return on Capital (ROIC) | 4.11% | 4.28% | 3.11% | 2.80% | 2.28% | 2.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.30% | 6.40% | 4.70% | 4.30% | 3.40% | 4.00% | Upgrade
|
| Earnings Yield | 7.09% | 7.06% | 4.76% | 3.87% | 3.25% | 1.70% | Upgrade
|
| FCF Yield | 3.09% | 1.67% | 1.79% | 1.60% | 5.25% | 0.36% | Upgrade
|
| Dividend Yield | 2.77% | 2.08% | 2.33% | 2.38% | 2.55% | 1.34% | Upgrade
|
| Payout Ratio | 40.50% | 29.96% | 47.09% | 57.22% | 70.81% | 73.58% | Upgrade
|
| Buyback Yield / Dilution | 3.19% | 4.27% | 3.03% | 2.29% | 0.63% | 0.56% | Upgrade
|
| Total Shareholder Return | 5.93% | 6.35% | 5.35% | 4.68% | 3.18% | 1.90% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.